Inspire Medical Systems (NYSE:INSP) Price Target Raised to $60.00

Posted by Stanley Muller on Aug 7th, 2026

Inspire Medical Systems (NYSE:INSP – Free Report) had its price target boosted by JPMorgan Chase & Co. from $54.00 to $60.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other equities research analysts also recently weighed in on INSP. Summit Redstone set a $39.00 target price on Inspire Medical Systems in a report on Friday, May 22nd. Piper Sandler upped their price target on shares of Inspire Medical Systems from $55.00 to $60.00 and gave the company a “neutral” rating in a research note on Tuesday. Truist Financial reaffirmed a “hold” rating and set a $62.00 price target (up from $54.00) on shares of Inspire Medical Systems in a research report on Tuesday. KeyCorp reiterated a “sector weight” rating on shares of Inspire Medical Systems in a research note on Tuesday. Finally, Wells Fargo & Company cut their price objective on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a report on Tuesday, May 5th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Inspire Medical Systems presently has a consensus rating of “Hold” and an average price target of $68.00.

Check Out Our Latest Stock Analysis on Inspire Medical Systems

Inspire Medical Systems Trading Down 2.0%

NYSE:INSP opened at $58.91 on Tuesday. The stock has a market cap of $1.70 billion, a P/E ratio of 12.75, a PEG ratio of 4.55 and a beta of 0.70. The stock has a 50 day simple moving average of $47.26 and a 200 day simple moving average of $54.48. Inspire Medical Systems has a 1-year low of $38.91 and a 1-year high of $147.03.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The business had revenue of $200.58 million during the quarter, compared to the consensus estimate of $194.72 million. During the same period in the previous year, the company posted $0.45 EPS. The firm’s quarterly revenue was down 7.6% on a year-over-year basis. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. As a group, sell-side analysts forecast that Inspire Medical Systems will post 1.24 EPS for the current year.

Institutional Trading of Inspire Medical Systems

Institutional investors have recently modified their holdings of the stock. Wellington Management Group LLP acquired a new position in Inspire Medical Systems in the fourth quarter valued at about $203,929,000. Wasatch Advisors LP lifted its position in Inspire Medical Systems by 7.2% during the second quarter. Wasatch Advisors LP now owns 1,634,395 shares of the company’s stock worth $212,095,000 after purchasing an additional 110,288 shares during the period. Morgan Stanley grew its stake in Inspire Medical Systems by 179.5% during the fourth quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock worth $116,188,000 after buying an additional 809,121 shares in the last quarter. Deerfield Management Company L.P. grew its stake in Inspire Medical Systems by 648.4% during the third quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock worth $77,739,000 after buying an additional 907,694 shares in the last quarter. Finally, State Street Corp increased its holdings in Inspire Medical Systems by 2.3% in the 2nd quarter. State Street Corp now owns 1,030,902 shares of the company’s stock valued at $133,780,000 after buying an additional 22,843 shares during the period. 94.91% of the stock is currently owned by institutional investors.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.